Dr Dodul Mondal is a Senior Consultant Radiation Oncologist at Indraprastha Apollo Hospitals, New Delhi, and has trained at AIIMS, Delhi, Cancer Institute of New Jersey, USA. Over the last decade, Dr. Mondal has amassed comprehensive knowledge and immense experience treating malignancies such as breast cancer, gastrointestinal cancer, genitourinary cancer, head and neck cancer, pediatric and hematologic Malignancies, gynecologic malignancies and brain tumours. In this article, he discusses the impact of COVID-19 on treatment decisions in brain tumours.
The world has been rattled by the ongoing Coronavirus infection (COVID19) which started from the city of Wuhan, China somewhere in late 2019. By this time, more than twenty lakh people worldwide are infected causing more than one lakh deaths involving more than two hundred countries. Whereas the United States is currently the most affected country both in terms of the number of cases and the number of deaths, India is also waiting to know its fate in the long run and so far, well-controlled.
In 2018, WHO estimated almost 9.6 million deaths worldwide due to cancer (almost 1 in every 6 deaths). Many of these cancers require immediate attention and treatment. Delay in treatment is known to jeopardize treatment outcomes in most situations.
When the entire world is busy fighting the highly contagious virus infection, cancer patients are finding it difficult to understand and respond to this situation adequately. Even oncologists across the globe are in a fix due to a lack of data on coronavirus infection and its implication on cancer patients. Which is more important? To treat or not to treat? How to treat? Which cancer is safer to wait for? Which cancer is dangerous to wait? Many questions are there without having any single answer. Cancer specific data in COVID patients or vice versa are very less at present. Only one Chinese data with roughly 2000 patients from 575 hospitals across 31 provinces is available to us so far. They identified 18 patients with history of cancer. This rate is higher than their usual national cancer occurrence pattern suggesting slightly higher risk of cancer in patients being affected with coronavirus infection. Also, patients with cancer had more severe events. However, eighteen is too small a number to draw any conclusion. Another fact was most of the patients were having lung cancer. Specific data are lacking pertaining to brain tumour at this moment.
Here are, some useful discussion out of common understanding and basic principles of infection and cancer care coupled with excerpts of available evidence so far in this situation on brain tumours.
Let me put it in this way, all patients coming to hospital need almost same basic precautions. A useful summary can be outlined this way:
It needs special mentioning that, none of the precautions including use of colony stimulating factor are proven to prevent or mitigate corona virus infection or its consequences.
Traditionally brain tumours are not staged in a classical manner like other cancers. Brain tumours are classified either as benign or malignant. Malignant tumours are again divided as per their pathological grades into high grade or low grade and so on.
Let us make it simple. COVID19 has not changed management protocol of brain tumours yet. If this continues, there might be some guidelines pouring in from large bodies like ASTRO/ESTRO/ASCO for brain tumour patients as well.
It may be justified to discuss with your team of doctors (including radiation oncologist, neurosurgeon, and/or medical oncologist to understand gravity of your condition, standard of care for your type of tumour, whether alternatives are available with equal efficacy or not etc.
Let me give an example, you can discuss options of radiosurgery instead of surgical removal of tumour to reduce your hospital stay. However, radiosurgery is not “magic treatment” for all brain tumours. It can be done only for some very selective conditions like AVM (arteriovenous malformation), pituitary adenoma, craniopharyngioma, small limited number of metastatic lesions, meningioma, schwannoma etc.
It is important to understand that there is no “one size fits all” concept in cancer care. Every patient is different from the other in terms of their tumour, its behaviour, necessary treatment, potential side effects, necessity of supportive care and so on. It is important to identify individual need and customize treatment in a personalized approach.
Although it is not justified to answer in a single word, following examples can help in deciding the immediate necessity of treatment.
Example 1: Mr X has been incidentally diagnosed with a meningioma without any significant problem and does not have immediate risk of neurological complication. Perhaps, he can wait after discussing with his team of doctors.
Example 2: Mr X has been diagnosed with a meningioma with significant neurological problem (like raised intracranial tension, progressive and rapid loss of vision, impending visual loss, impending spinal cord compression etc.). For him it would be necessary to seek for immediate medical attention and he should not wait for COVID situation to become normal.
Example 3: Ms Y has been diagnosed with suspected highgrade glioma. It is justified and necessary to seek immediate medical attention and proceed for further treatment. The patient, family members and treating hospital must take all necessary precautions to avoid risk of infection.
Example 4: Baby Z has been diagnosed to have suspected medulloblastoma after initial evaluation for her vomiting, loss of balance and frequent fall. She will require medical attention and treatment for her tumour at the earliest possible time.
Many more examples can be given. On a simpler note, any tumour, which is immediately life threatening or can cause rapid neurological deterioration or aggressive in behaviour (like a glioblastoma) should be treated immediately with surgery, radiation, chemotherapy, or different combinations of them as per indication. It is advisable that patients discuss with experienced doctor in this field.
For how long can one wait will also depend on exact nature or suspected nature of their illness which only an experienced doctor can decide on a case to case basis.
All general precautions as outlined above. Additionally:
At the end, it is to be remembered that, the effect between treatment, overall treatment time and expected benefits are all interlinked in a complex manner which varies in between patients and tumours. To suggest an idealistic and holistic approach in this crucial time should be the job of your doctor. Discuss all relevant concerns with them before deciding whether “To Treat or Not to Treat”?
కీమోథెరపీ కోసం క్యాన్సర్ రోగులు ఎలాంటి దుస్తులు ధరించాలో తెలుసా? ఈ ఆర్టికల్లో, క్యాన్సర్ రోగులకు కీమోథెరపీని సౌకర్యవంతంగా పొందడంలో సహాయపడే దుస్తుల జాబితాను అందించాము.
ఈ కథనం మీ క్యాన్సర్ రకానికి సరైన క్యాన్సర్ వైద్యుడిని కనుగొనడానికి 6-దశల గైడ్ను వివరిస్తుంది.
तंबाकू का सेवन गुटका, जर्दा, पैन मसाला आदि के रूप में करना सिर और गले के कैंसर का मुख्य कारण…
నోటి పుండ్లతో బాధపడుతున్న క్యాన్సర్ రోగులకు క్యాన్సర్ చికిత్సలో ఉన్నప్పుడు తీసుకోవాల్సిన 12 ఉత్తమ ఆహారాలు.
క్యాన్సర్కు కారణమయ్యే 6 జీవనశైలి కారకాలు గురించి ఈ కథనంలో వివరంగా ఇవ్వబడ్డాయి. అవి ఏమిటో తెలుసుకోండి!
शोध की मानें तो न्यूज़पेपर प्रिंट करने में जो स्याही का इस्तेमाल होता है उसमें ऐसे केमिकल होते हैं जो…